InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Browse the full record of transactions filed by Denyes Nancy. Officer active across 2 companies, notably aTYR PHARMA INC. In total, 5 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 5 June 2024. The latest transaction was filed on 5 June 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
DENYES NANCY is a declarant linked to aTYR PHARMA INC, where she serves as General Counsel. She has 5 filings in total, and in the recent filings tracked, buys amount to EUR 8530 with no sales, over the period from 2023-02-06 to 2026-02-04. The modal transaction nature is Levée d'options.